Healthcare & Life Sciences
Plexium
United Statesplexium.com
Plexium is a series c plus startup based in United States. 2 investors tracked.
activeseries-b
series-b
Stage
2018
Founded
4
Investors
About Plexium
Plexium is a startup founded in 2018 based in the United States. Its most recent tracked round is Series B. Brouky records 4 investors associated with the company.
Plexium is a biotechnology company focused on targeted protein degradation (TPD). It utilizes a proprietary platform to discover and develop small molecule therapeutics that induce the selective degradation of drug target proteins through E3 ligase-mediated proteasomal degradation, addressing previously 'undruggable' targets for cancer and neurodegenerative diseases.
Explore Plexium's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.